Search
InsiderInsights.com

Siegall Clay B (1167496)

Siegall Clay B has been a registered insider at 3 firms since 2003. As Chief Executive Officer at Seattle Genetics, Inc., Siegall Clay B last made a transaction on 5/12/2022. As a Director at Ultragenyx Pharmaceutical, Siegall Clay B last made a transaction on 8/10/2020. As a Director at Alder BioPharmaceuticals, Siegall Clay B last made a transaction on 11/1/2017.

SEATTLE GENETICS INC /WA (SGEN)

Titles: PR,CEO,DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
14 79% 17% 8% 82 1 Year 14 0% -- -- --
14 64% 15% 15% 86 9 Month 14 0% -- -- --
14 50% 7% -1% 69 6 Month 14 0% -- -- --
14 50% 3% 1% 64 3 Month 14 0% -- -- --
14 64% 5% 3% 54 1 Month 14 0% -- -- --
14 79% 3% 4% 18 1 Week 14 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
152 31% 23% 11% 198 1 Year 152 0% -- -- --
152 42% 16% 6% 153 9 Month 152 0% -- -- --
152 43% 12% 6% 123 6 Month 152 0% -- -- --
152 41% 6% 5% 102 3 Month 152 0% -- -- --
152 43% 2% 2% 61 1 Month 152 0% -- -- --
152 48% -0% 1% 40 1 Week 152 0% -- -- --
Scorecards Updated 6/14/2023 12:08 PM EST Latest Transaction Date: 5/12/2022
Average days between Transaction and Entered Dates: 2

Ultragenyx Pharmaceutical Inc. (RARE)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 0% 12% -- -- 1 Year 1 0% -- -- --
1 0% 31% -- -- 9 Month 1 0% -- -- --
1 0% 102% -- -- 6 Month 1 0% -- -- --
1 0% 42% -- -- 3 Month 1 0% -- -- --
1 100% -10% -- -- 1 Month 1 0% -- -- --
1 0% 6% -- -- 1 Week 1 0% -- -- --
Scorecards Updated 6/14/2023 12:08 PM EST Latest Transaction Date: 8/10/2020
Average days between Transaction and Entered Dates: 1

ALDER BIOPHARMACEUTICALS INC (ALDR)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 100% 31% -- -- 1 Year 1 0% -- -- --
1 100% 74% -- -- 9 Month 1 0% -- -- --
1 100% 21% -- -- 6 Month 1 0% -- -- --
1 100% 26% -- -- 3 Month 1 0% -- -- --
1 0% -1% -- -- 1 Month 1 0% -- -- --
1 100% 2% -- -- 1 Week 1 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 100% -33% -- -- 1 Year 1 0% -- -- --
1 100% -47% -- -- 9 Month 1 0% -- -- --
1 100% -15% -- -- 6 Month 1 0% -- -- --
1 100% -4% -- -- 3 Month 1 0% -- -- --
1 0% 15% -- -- 1 Month 1 0% -- -- --
1 100% -3% -- -- 1 Week 1 0% -- -- --
Scorecards Updated 6/14/2023 12:08 PM EST Latest Transaction Date: 11/1/2017
Average days between Transaction and Entered Dates: 1
© 2024 InsiderInsights.com